USE OF AN AUREOLYSIN INHIBITOR FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS CHARACTERISED BY COLONISATION WITH STAPHYLOCOCCUS AUREUS
申请人:Serentis Limited
公开号:EP1931624A1
公开(公告)日:2008-06-18
[EN] USE OF AN AUREOLYSIN INHIBITOR FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS CHARACTERISED BY COLONISATION WITH STAPHYLOCOCCUS AUREUS<br/>[FR] UTILISATION D'UN INHIBITEUR DE L'AUREOLYSINE POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES DE LA PEAU CARACTERISEES PAR UNE COLONISATION PAR STAPHYLOCOCCUS AUREUS
申请人:SURFACE THERAPEUTICS LTD
公开号:WO2007025999A1
公开(公告)日:2007-03-08
[EN] There is provided, inter alia, a method for the treatment or prevention of an inflammatory skin condition which is characterised by colonisation with Staphylococcus aureus, comprising the topical administration of an aureolysin inhibitor. [FR] L'invention concerne notamment une méthode de traitement ou de prévention d'une maladie inflammatoire de la peau caractérisées par une colonisation par Staphylococcus aureus, cette méthode consistant en l'administration topique d'un de l'auréolysine.
WO2007/25999
申请人:——
公开号:——
公开(公告)日:——
Novel method of treatment of inflammatory skin conditions
申请人:Chandler Rupert Stephen
公开号:US20070049518A1
公开(公告)日:2007-03-01
There is provided, inter alia, a method for the treatment or prevention of an inflammatory skin condition which is characterised by colonisation with
Staphylococcus aureus
, comprising the topical administration of an aureolysin inhibitor.